XEPRILA
sanofi-aventis
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77500476 |
| Registration Number | 3776729 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | G. Mathew Lombard |
| Attorney Name | G. Mathew Lombard |
| Attorney Docket Number | 101.0514 |
| Law Office Assigned | M50 |
| Employee Name | LEWIS, SHAILA E |
Timeline
| 2008-06-17 | Application Filed |
| 2009-03-31 | Published for Opposition |
| 2010-04-20 | Location: PUBLICATION AND ISSUE SECTION |
| 2010-04-20 | Trademark Registered |
| 2016-11-25 | Cancelled |
| 2016-11-25 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  sanofi-aventis |
| Entity Statement | SOCIÃTÃ ANONYME (SA) |
| Address | 174, avenue de France Paris FR 75013 |
| Legal Entity Type | |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the prevention and treatment of diseases of the central nervous system |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2008-06-20 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2008-08-08 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2008-08-12 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2008-08-12 | 4 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2008-08-12 | 5 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2009-02-03 | 6 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2009-02-05 | 7 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2009-02-06 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2009-02-06 | 9 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2009-02-23 | 10 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2009-02-24 | 11 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2009-03-11 | 12 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2009-03-31 | 13 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2009-06-23 | 14 NOAM O:Outgoing Correspondence |
| TEAS DELETE 1(B) BASIS RECEIVED | 2010-01-22 | 15 D1BR I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2010-02-12 | 16 AITU A:Allowance for Publication |
| TEAS EXTENSION RECEIVED | 2009-12-23 | 17 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2009-12-23 | 18 EXT1 S: |
| EXTENSION 1 GRANTED | 2010-03-11 | 19 EX1G S: |
| NOTICE OF ALLOWANCE CANCELLED | 2010-03-11 | 20 IUCN S: |
| 1(B) BASIS DELETED; PROCEED TO REGISTRATION | 2010-03-11 | 21 DP1B I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2010-04-20 | 22 R.PR A:Allowance for Publication |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2010-12-23 | 23 TCCA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2015-04-20 | 24 REM1 E:E-Mail |
| CANCELLED SEC. 8 (6-YR) | 2016-11-25 | 25 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 XEPRILA 77500476 3776729 Dead/Cancelled |
sanofi-aventis 2008-06-17 |
 XEPRILA 76059023 2796500 Dead/Cancelled |
SANOFI-AVENTIS 2000-05-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 